Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.64 -0.16 (-0.85%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Restructuring Costs (2025)

Updated

Sarepta Therapeutics (SRPT) recorded Restructuring Costs of $1.5 million in Q4 2025, down 96.3% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Restructuring Costs (2025) Analysis & Trends

For FY2025, Sarepta Therapeutics reported Restructuring Costs of $42.01 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Sarepta Therapeutics 1.99 Bn -1.25 Bn 251.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.50 Mn
Sep 30, 2025 40.51 Mn
API Access

Sarepta Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=SRPT&period=max&api_key=YOUR_API_KEY